{
    "AML": {
        "Induction Therapy": {
            "goal": "The goal is to rapidly clear leukemia cells (blasts) from the blood and bone marrow to achieve <b>Complete Remission (CR)</b> and restore normal blood cell production.",
            "protocols": [
                {
                    "protocolName": "7+3 (Cytarabine + Daunorubicin/Idarubicin)",
                    "drugs": [
                        {
                            "phase": "Pre-Chemo",
                            "day": "Day 1 - 7",
                            "name": "Ondansetron",
                            "dose": "8 mg Daily",
                            "route": "IV over 15 mnts",
                            "duration": "15 min",
                            "note": "15 minutes before chemo"
                        },
                        {
                            "phase": "Pre-Chemo",
                            "day": "Day 1 - 10",
                            "name": "Prednisolone 1%",
                            "dose": "1 drop Q6H",
                            "route": "Eye drops",
                            "duration": "every 6 hours",
                            "note": "2 hours before start of Cytarabine"
                        },
                        {
                            "phase": "Chemo",
                            "day": "Days 1 – 3",
                            "name": "Daunorubicin or Idarubicin",
                            "dose": "60 mg/m²/day over 5-15 min or 12 mg/m²/day over 10-15 min",
                            "route": "IV",
                            "duration": "3 days",
                            "note": "Check cardiac function before starting, Use central venous line (PICC/CVC) for Idarubicin / Daunorubicin - avoid peripheral veins."
                        },
                        {
                            "phase": "Chemo",
                            "day": "Days 1 – 7",
                            "name": "Cytarabine (Ara-C)",
                            "dose": "100 mg/m²/day",
                            "route": "IV continuous infusion",
                            "duration": "7 days",
                            "note": "Hydrate well during chemotherapy administration"
                        },
                        {
                            "phase": "Post-Chemo",
                            "day": "Days 1 – 28",
                            "name": "Acyclovir",
                            "dose": "200 mg BID",
                            "route": "PO",
                            "duration": "28 days",
                            "note": "prophylaxis for viral infections"
                        },
                        {
                            "phase": "Post-Chemo",
                            "day": "Days 1 – 21",
                            "name": "Voriconazole",
                            "dose": "200 mg BID",
                            "route": "PO",
                            "duration": "21 days",
                            "note": "Prophylaxis for fungal infections"
                        }
                    ],
                    "NursesInfo": [
                        "<b>Verify Cardiac Baseline:</b> Confirm documented Echo or MUGA scan shows EF ≥ 50% prior to Idarubicin administration.",
                        "<b>Monitor Cytarabine Toxicity:</b> Assess for Cytarabine-induced skin rash and provide prophylactic steroid eye drops for conjunctivitis.",
                        "<b>Track TLS Risk:</b> Monitor strict I/O and daily weights to identify early signs of Tumor Lysis Syndrome.",
                        "<b>Assess Mucosal Integrity:</b> Perform daily oral assessments for mucositis and ensure using Mucositis formula if required.",
                        "<b>Monitor Hematologic Recovery:</b> Track ANC and platelets daily; implement strict neutropenic precautions during the expected nadir."
                    ],
                    "source": "Hospital Protocol"
                },
                {
                    "protocolName": "FLAG-IDA (Fludarabine + Cytarabine + G-CSF + Idarubicin)",
                    "drugs": [
                        {
                            "day": "Day 1 - until ANC recovery",
                            "name": "Filgrastim (G-CSF)",
                            "dose": "300 mcg Daily",
                            "route": "SC",
                            "duration": "",
                            "phase": "Pre-Chemo",
                            "note": "Continue until ANC >1000 in two consecutive days"
                        },
                        {
                            "day": "Days 2 – 4",
                            "name": "Idarubicin",
                            "dose": "10 mg/m² Daily",
                            "route": "IV over 15 mnts",
                            "duration": "",
                            "phase": "Chemo",
                            "note": "Check cardiac function before starting"
                        },
                        {
                            "day": "Days 2 – 6",
                            "name": "Fludarabine",
                            "dose": "30 mg/m² Daily",
                            "route": "IV over 30 min",
                            "duration": "",
                            "phase": "Chemo",
                            "note": ""
                        },
                        {
                            "day": "Days 2 – 6",
                            "name": "Cytarabine",
                            "dose": "2 g/m² Daily",
                            "route": "IV over 4 hrs",
                            "duration": "",
                            "phase": "Chemo",
                            "note": "4 hours after Fludarabine"
                        }
                    ],
                    "NursesInfo": [
                        "<b>Verify Cardiac Baseline:</b> Ensure baseline EF ≥ 50% is documented prior to Idarubicin administration.",
                        "<b>Monitor Fludarabine Neurotoxicity:</b> Assess for changes in mental status or peripheral neuropathy related to Fludarabine.",
                        "<b>Track Prolonged Neutropenia:</b> Prepare for extended myelosuppression; implement strict infection control and growth factor support.",
                        "<b>Confirm TLS Prophylaxis:</b> Monitor for Tumor Lysis Syndrome; ensure adequate hydration and Allopurinol/Rasburicase are active.",
                        "<b>Assess Line Integrity:</b> Verify brisk blood return prior to Idarubicin infusion to mitigate high extravasation risk."
                    ],
                    "source": "Hospital Protocol"
                },
                {
                    "protocolName": "FA (Fluderabine + Cytarabine)",
                    "drugs": [
                        {
                            "name": "Ondansetron",
                            "dose": "8mg Q24H",
                            "route": "IV over 15 mints",
                            "phase": "Pre-Chemo",
                            "day": "Day 1 - 5",
                            "duration": "",
                            "note": "15 minutes before Fluderabine"
                        },
                        {
                            "name": "Allopurinol",
                            "dose": "300mg Daily",
                            "route": "PO",
                            "phase": "Pre-Chemo",
                            "day": "Day 1 - 7",
                            "duration": "",
                            "note": ""
                        },
                        {
                            "name": "Prednisolone 1%",
                            "dose": "1 drops QID",
                            "route": "Eye drops",
                            "phase": "Pre-Chemo",
                            "day": "Day 1 - 10",
                            "duration": "",
                            "note": "Start 2 hours before Cytarabine"
                        },
                        {
                            "name": "Fluderabine",
                            "dose": "30mg/m² Q24H",
                            "route": "IV over 30 mints",
                            "phase": "Chemo",
                            "day": "Day 1 - 5",
                            "duration": "",
                            "note": ""
                        },
                        {
                            "name": "Cytarabine ",
                            "dose": "2000mg Q24H",
                            "route": "IV over 4 hours",
                            "phase": "Chemo",
                            "day": "Day 1 - 5",
                            "duration": "",
                            "note": "4 hours after start of Fluderabine"
                        },
                        {
                            "name": "Bactrim",
                            "dose": "1 tablet Q48H",
                            "route": "PO",
                            "phase": "Post-Chemo",
                            "day": "Day 1 - 21",
                            "duration": "",
                            "note": ""
                        },
                        {
                            "name": "Acyclovir",
                            "dose": "200mg BID",
                            "route": "PO",
                            "phase": "Post-Chemo",
                            "day": "Day 1 - 21",
                            "duration": "",
                            "note": ""
                        },
                        {
                            "name": "Voriconazole",
                            "dose": "200mg BID",
                            "route": "PO",
                            "phase": "Post-Chemo",
                            "day": "Day 1 - 21",
                            "duration": "",
                            "note": ""
                        }
                    ],
                    "NursesInfo": [
                        "<b>Monitor Cerebellar Function:</b> Perform regular neuro checks to identify Cytarabine-induced ataxia or nystagmus.",
                        "<b>Assess Pulmonary Status:</b> Monitor for dyspnea or cough as Fludarabine and Ara-C can rarely cause pulmonary toxicity.",
                        "<b>Track Neutropenic Nadir:</b> Monitor for severe infection risk due to high-dose synergistic myelosuppression.",
                        "<b>Manage Ocular Care:</b> Ensure the patient uses prophylactic saline or steroid eye drops throughout the Ara-C infusion.",
                        "<b>Monitor Renal Function:</b> Track creatinine levels to ensure appropriate clearance of Fludarabine metabolites."
                    ],
                    "source": "Hospital Protocols"
                }
            ]
        },
        "Consolidation Therapy": {
            "goal": "The goal is to eliminate any <b>Minimal Residual Disease (MRD)</b>—undetectable leukemia cells—to prevent relapse and maintain long-term remission.",
            "protocols": [
                {
                    "protocolName": "IDAC (Intermediate Dose Ara-C)",
                    "drugs": [
                        {
                            "day": "Day 1 - 7",
                            "name": "Prednisolone 1%",
                            "dose": "1 drops Q6H",
                            "route": "Eye drops",
                            "duration": "",
                            "phase": "Pre-Chemo",
                            "note": "Start 2 before start of Cytarabine"
                        },
                        {
                            "name": "Cytarabine (Ara-C)",
                            "dose": "1.5 g/m² Q12H",
                            "route": "IV over 3 hrs ",
                            "phase": "Chemo",
                            "day": "Days 1 – 3",
                            "note": ""
                        }
                    ],
                    "NursesInfo": [
                        "Indication: AML in remission in patients who are under 60 years of age.",
                        "Side effects: \"Cytarabine syndrome\", \"Tumour lysis syndrome\", Cytarabine induced neurotoxicity, Nausea and Vomiting"
                    ],
                    "source": "Hospital Protocol"
                },
                {
                    "protocolName": "HiDAC-High dose Cytarabine (Ara-c)",
                    "drugs": [
                        {
                            "day": "Day 1 - 10",
                            "name": "Prednisolone 1%",
                            "dose": "1 drop Q6H",
                            "route": "Eye drop",
                            "duration": "",
                            "phase": "Pre-Chemo",
                            "note": ""
                        },
                        {
                            "name": "Cytarabine (Ara-C)",
                            "dose": "3gm/m² Q12H",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Days 1, 3, 5",
                            "note": ""
                        }
                    ],
                    "NursesInfo": [
                        "<b>Perform Neuro Checks:</b> Assess cerebellar function (handwriting, gait, finger-to-nose) before every dose to detect Ara-C induced ataxia.",
                        "<b>Administer Ocular Prophylaxis:</b> Ensure corticosteroid eye drops are administered 2 hours prior to initial dose Cytarabine and then every 6 hours to prevent chemical conjunctivitis.",
                        "<b>Monitor for Cytarabine Syndrome:</b> Track for fever, myalgia, bone pain, and rash occurring typically 6–12 hours after administration.",
                        "<b>Track Neutropenic Nadir:</b> Monitor CBC daily; implement strict infection control due to expected profound myelosuppression.",
                        "<b>Maintain Skin Integrity:</b> Assess for Ara-C induced hand-foot syndrome or maculopapular rash and provide topical emollients as needed."
                    ],
                    "source": "Hospital Protocol"
                }
            ]
        },
        "Maintenance Therapy": {
            "goal": "The goal is to provide <b>prolonged, low-intensity therapy</b> to suppress any remaining leukemia cells and reduce the risk of recurrence, especially in patients ineligible for stem cell transplant.",
            "protocols": [
                {
                    "protocolName": "Azacitidine SC",
                    "drugs": [
                        {
                            "day": "Days 1 – 7 ",
                            "name": "Azacitidine",
                            "dose": "75 mg/m²",
                            "route": "SC",
                            "duration": "Q28 Days upto 6 cycles",
                            "phase": "Chemo",
                            "note": ""
                        }
                    ],
                    "NursesInfo": [
                        "Premediication Ondansetron oral",
                        "Nausea, vomiting, and diarrhea are common.",
                        "Can also be administered as IV"
                    ],
                    "source": "Hospital Protocol"
                }
            ]
        }
    },
    "ALL": {
        "ALL": {
            "Induction Phase": {
                "goal": "The goal is to quickly eradicate lymphoid blasts to reach <b>Complete Remission (CR)</b> and provide <b>CNS prophylaxis</b> to prevent leukemia from spreading to the brain or spinal cord.",
                "protocols": [
                    {
                        "protocolName": "HyperCVAD Cycle A (1, 3, 5)",
                        "drugs": [
                            {
                                "name": "Ondansetron",
                                "dose": "8mg",
                                "route": "Iv over 15 mnts",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 5",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Dexamthasone",
                                "dose": "40mg",
                                "route": "PO Daily",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 4",
                                "duration": "",
                                "note": "Repeat after 1 week Day 8 - 11"
                            },
                            {
                                "name": "Mesna",
                                "dose": "600mg/m²",
                                "route": "IV over 24 hrs",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 3",
                                "duration": "",
                                "note": "Start 5 minutes after finish of Ondansetron"
                            },
                            {
                                "name": "Cyclophosphamide",
                                "dose": "300mg/m² Q12H",
                                "route": "IV over 2 hours",
                                "phase": "Chemo",
                                "day": "Day 1 - 3",
                                "duration": "",
                                "note": "Start 5 minutes after start of Mesna"
                            },
                            {
                                "name": "Doxorubicin",
                                "dose": "50mg/m²  Once",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 4",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Vincristine",
                                "dose": "1.4mg/m² Once",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 4, Day 11",
                                "duration": "",
                                "note": "Make sure patient has bowel motion on the day of administration."
                            },
                            {
                                "name": "Dexamethasone",
                                "dose": "40mg Daily",
                                "route": "PO",
                                "phase": "Pre-Chemo",
                                "day": "Day 11 - 14",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Alfacalcidol",
                                "dose": "0.25mg Daily",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": "TLS prophylaxis"
                            },
                            {
                                "name": "Acyclovir",
                                "dose": "200mg BID",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Fluconazole",
                                "dose": "300mg Daily",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Bactrim",
                                "dose": "1 tab Q48H",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Filgrastim (GCSF)",
                                "dose": "300mg Daily",
                                "route": "SC",
                                "phase": "Post-Chemo",
                                "day": "Day 7 - ",
                                "duration": "",
                                "note": "Until ANC >1000 in two consecutive days"
                            }
                        ],
                        "NursesInfo": [
                            "<b>Verify Cardiac Baseline:</b> Confirm a documented Echo or MUGA scan within 6 months shows EF ≥ 50% prior to Cyclophosphamide administration.",
                            "<b>Confirm Mesna Timing:</b> Ensure Mesna infusion is synchronized correctly with Cyclophosphamide to prevent hemorrhagic cystitis.",
                            "<b>Monitor Steroid Impact:</b> Check blood glucose levels frequently due to the high-dose Dexamethasone component.",
                            "<b>Audit CNS Prophylaxis:</b> Ensure Intrathecal (IT) chemotherapy is synchronized with the systemic window as per the roadmap.",
                            "<b>Assess Port Patency:</b> Perform a brisk blood return check on the CVAD immediately before hanging vesicants or high-volume infusions."
                        ],
                        "source": "Hospital Protocol"
                    },
                    {
                        "protocolName": "HyperCVAD Cycle B (2, 4, 6)",
                        "drugs": [
                            {
                                "name": "Ondanasetron",
                                "dose": "8mg Daily",
                                "route": "IV over 15 mnts",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 4",
                                "note": ""
                            },
                            {
                                "name": "Dexamethasone",
                                "dose": "12mg Daily",
                                "route": "IV over 10 mnts",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 3",
                                "note": ""
                            },
                            {
                                "name": "Sodium Bicarbonate",
                                "dose": "975mg TID",
                                "route": "PO",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - until MTX clearence",
                                "note": "Until MTX level <0.1"
                            },
                            {
                                "name": "Sodium Bicarbonate",
                                "dose": "450mmol/L Daily",
                                "route": "IV infusion",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - until MTX clearence",
                                "note": "Until MTX level <0.1"
                            },
                            {
                                "name": "Methotrexate",
                                "dose": "200mg/m² Once",
                                "route": "IV over 2 hrs",
                                "phase": "Chemo",
                                "day": "Day 2",
                                "note": "After urine pH >8"
                            },
                            {
                                "name": "Methotrexate",
                                "dose": "200mg/m² Once",
                                "route": "IV over 22 hrs",
                                "phase": "Chemo",
                                "day": "Day 2",
                                "note": "After first bag of Methotrexate (MTX)"
                            },
                            {
                                "name": "Methotrexate",
                                "dose": "12mg Once",
                                "route": "IT",
                                "phase": "Chemo",
                                "day": "Day 3",
                                "note": "Intrathecal chemo, After MTX."
                            },
                            {
                                "name": "Prednisolone 1%",
                                "dose": "1 drop Q6H",
                                "route": "Eye drops",
                                "phase": "Pre-Chemo",
                                "day": "Day 4 - 10",
                                "note": "Start 2 hours before the first dose Cytarabine. "
                            },
                            {
                                "name": "Cytarabine",
                                "dose": "300mg/m² Q12H",
                                "route": "IV over 3 hrs",
                                "phase": "Chemo",
                                "day": "Day 4 - 5",
                                "note": "2 hours after finish of MTX"
                            },
                            {
                                "name": "Calcium folinate",
                                "dose": "25mg Q6H",
                                "route": "IV",
                                "phase": "Post-Chemo",
                                "day": "Day 4 - until MTX clearence",
                                "note": "Start 36 hours AFTER the START of second MTX"
                            },
                            {
                                "name": "Cytarabine",
                                "dose": "100mg Once",
                                "route": "IT",
                                "phase": "Chemo",
                                "day": "Day 8",
                                "note": "Intrathecal chemo"
                            },
                            {
                                "name": "Bactrim",
                                "dose": "960mg Q48H",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "note": "Hold While MTX and until clearence"
                            },
                            {
                                "name": "Acyclovir",
                                "dose": "200mg BID",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "note": "Prophylactic"
                            },
                            {
                                "name": "Fluconazole",
                                "dose": "300mg Daily",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "note": "Hold if any other Antifungal active"
                            },
                            {
                                "name": "Filgrastim",
                                "dose": "300mg Daily",
                                "route": "SC",
                                "phase": "Chemo",
                                "day": "Day 6 -",
                                "note": "Continue until ANC >1000 in 2 consecutive days"
                            }
                        ],
                        "NursesInfo": [
                            "<b>Validate Urine Alkalinization:</b> Confirm urine pH is > 7.0 prior to starting High-Dose Methotrexate to prevent renal precipitation.",
                            "<b>Monitor Neurotoxicity:</b> Perform handwriting and gait assessments to screen for Cytarabine-induced cerebellar toxicity.",
                            "<b>Execute Leucovorin Rescue:</b> Ensure Leucovorin is administered exactly at the scheduled intervals until Methotrexate levels are safe.",
                            "<b>Monitor Renal Clearance:</b> Track serum creatinine and maintain aggressive hydration (>100 mL/hr) during Methotrexate infusion.",
                            "<b>Audit CNS Prophylaxis:</b> Coordinate timing for Intrathecal (IT) Methotrexate and or Cytarabine as specified for Cycle B.",
                            "<b>Monitor MTX Clearance:</b> Check urine pH every void after Sodium Bicarbonate start and daily after MTX start until level < 0.1 μmol/L.",
                            "<b>Audit MTX Levels:</b> Draw first MTX level 1 hour after second dose completion, then every 24 hours until level < 0.1 μmol/L."
                        ],
                        "source": "Hospital protocol"
                    },
                    {
                        "protocolName": "Mini HyperCVAD Cycle A",
                        "drugs": [
                            {
                                "name": "Ondansetron",
                                "dose": "8mg Daily",
                                "route": "IV",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 5",
                                "duration": "Over 15 mints",
                                "note": "15 minutes before chemo"
                            },
                            {
                                "name": "Allopurinol",
                                "dose": "300mg Daily",
                                "route": "PO",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 7",
                                "duration": "",
                                "note": "Before chemo"
                            },
                            {
                                "name": "Dexamethasone",
                                "dose": "20mg Daily",
                                "route": "PO",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 4",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Mesna",
                                "dose": "300mg/m² Daily",
                                "route": "IV",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 3",
                                "duration": "Over 24 hours",
                                "note": "Start 5 mints after Ondansetron "
                            },
                            {
                                "name": "Cyclophosphamide",
                                "dose": "150mg/m² Q12H",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 1 - 3",
                                "duration": "Over 3 hours",
                                "note": "Start 5 mints after MESNA start."
                            },
                            {
                                "name": "Methotrexate + Cytarabine + Hydrocortisone",
                                "dose": "(12mg + 50mg + 50mg) Once",
                                "route": "IT",
                                "phase": "Chemo",
                                "day": "Day 2",
                                "duration": "",
                                "note": "Intrathecal"
                            },
                            {
                                "name": "Vincristine",
                                "dose": "2mg Q1W",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 5, Day 12",
                                "duration": "Over 10 mints",
                                "note": "Give only if patient has bowel motion on the day. "
                            },
                            {
                                "name": "Dexamethasone",
                                "dose": "20mg Daily",
                                "route": "PO",
                                "phase": "Chemo",
                                "day": "Day 11 - 14",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Alfacalcidol",
                                "dose": "0.25mg Daily",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Acyclovir",
                                "dose": "200mg BID",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Fluconazole",
                                "dose": "400mg Daily",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Bactrim",
                                "dose": "1 tab Q48H",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Filgrastim (GCSF)",
                                "dose": "300mg Daily",
                                "route": "SC",
                                "phase": "Post-Chemo",
                                "day": "Day 6 - ",
                                "duration": "",
                                "note": "Continue until ANC >1000 in two consecutive days."
                            }
                        ],
                        "NursesInfo": [
                            "<b>Verify Cardiac Baseline:</b> Confirm a documented Echo or MUGA scan within 6 months shows EF ≥ 50% prior to Cyclophosphamide administration.",
                            "<b>Validate Dose Reductions:</b> Cross-check that the \"Mini\" doses (usually 50% reduction of Cyclophosphamide and Dexamethasone, and omitting Anthracyclines) match the age-adjusted or renal-adjusted parameters in the MAR.",
                            "<b>Confirm TLS Prophylaxis:</b> Verify that Allopurinol is started and the patient has achieved an aggressive fluid intake/output balance (typically >100 mL/hr to prevent Tumor Lysis Syndrome.",
                            "<b>Audit CNS Prophylaxis Timing:</b> Ensure the scheduled Intrathecal (IT) chemotherapy (Methotrexate and/or Cytarabine) is synchronized with the systemic Cycle A window as per the protocol roadmap.",
                            "<b>Assess Port/Line Patency:</b> Perform a brisk blood return check on the Central Venous Access Device (PICC) immediately before hanging vesicants or high-volume infusions to mitigate extravasation risk."
                        ],
                        "source": "Hospital Protocols"
                    },
                    {
                        "protocolName": "Mini HyperCVAD Cycle B",
                        "drugs": [
                            {
                                "name": "Ondansetron",
                                "dose": "8mg Daily",
                                "route": "IV",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 3",
                                "duration": "Over 15 mints",
                                "note": ""
                            },
                            {
                                "name": "Dexamethasone",
                                "dose": "12mg Daily",
                                "route": "IV",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 3",
                                "duration": "Over 10 mints",
                                "note": ""
                            },
                            {
                                "name": "Sodium Bicarbonate",
                                "dose": "975mg TID",
                                "route": "PO",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 -",
                                "duration": "",
                                "note": "Continue until ANC <0.1"
                            },
                            {
                                "name": "Sodium Bicarbonate",
                                "dose": "45mmol Daily",
                                "route": "IV",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 -",
                                "duration": "Over 24 hours",
                                "note": "Continue until ANC <0.1"
                            },
                            {
                                "name": "Methotrexate (MTX)",
                                "dose": "250mg/m² Once",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 2",
                                "duration": "Over 2 hours",
                                "note": "Start only if urine pH >8"
                            },
                            {
                                "name": "Methotrexate",
                                "dose": "12mg",
                                "route": "IT",
                                "phase": "Chemo",
                                "day": "Day 2",
                                "duration": "",
                                "note": "Intrathecal, may combine with Cytarabine and Hydrocortisone"
                            },
                            {
                                "name": "Calcium Folinate",
                                "dose": "25mg Q6H",
                                "route": "IV push",
                                "phase": "Chemo",
                                "day": "Day 3",
                                "duration": "",
                                "note": "Start 12 hours AFTER finish of MTX, then Q6H. Continue until MTX level <0.1"
                            },
                            {
                                "name": "Cytarabine",
                                "dose": "500mg/m² Q12H",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 3 - 4",
                                "duration": "Over 2 hours",
                                "note": "Start 24 hours AFTER finish of MTX, then Q12H (4 doses)"
                            },
                            {
                                "name": "Methotrexate",
                                "dose": "12mg",
                                "route": "IT",
                                "phase": "Chemo",
                                "day": "Day 7",
                                "duration": "",
                                "note": "Intrathecal, may combine with Cytarabine and Hydrocortisone"
                            },
                            {
                                "name": "Bactrim",
                                "dose": "1 tab Q48H",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Acyclovir",
                                "dose": "200mg BID",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Fluconazole",
                                "dose": "300mg Daily",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 21",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Filgrastim (GCSF)",
                                "dose": "300mg Daily",
                                "route": "SC",
                                "phase": "Post-Chemo",
                                "day": "Day 6 -",
                                "duration": "",
                                "note": "Continue until ANC >1000 two consecutive days"
                            }
                        ],
                        "NursesInfo": [
                            "<b>Validate Dose Reductions:</b> Cross-check that doses match the age-adjusted or renal-adjusted parameters (typically 50% reduction).",
                            "<b>Verify Anthracycline Omission:</b> Confirm that anthracyclines are omitted as per the \"mini\" protocol variation.",
                            "<b>Monitor Urine pH:</b> Ensure urine pH remains > 7.0 for Methotrexate clearance despite the reduced dosage.",
                            "<b>Assess Myelosuppression:</b> Monitor for prolonged cytopenias which may occur even with dose-reduced chemotherapy.",
                            "<b>Confirm Eye Care:</b> Administer steroid eye drops as ordered to mitigate Cytarabine-related chemical conjunctivitis.",
                            "<b>Monitor MTX Clearance:</b> Check urine pH every void after Sodium Bicarbonate start and daily after MTX start until level < 0.1 μmol/L.",
                            "<b>Audit MTX Levels:</b> Draw first MTX level 1 hour after second dose completion, then every 24 hours until level < 0.1 μmol/L."
                        ],
                        "source": "Hospital Protocol"
                    }
                ]
            }
        },
        "T-ALL": {
            "Induction / Post remission Phase": {
                "goal": "",
                "protocols": [
                    {
                        "protocolName": "DFCP (Dana-Farber Consortium Protocol)",
                        "drugs": [
                            {
                                "name": "Allopurinol",
                                "dose": "300mg",
                                "route": "PO",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 7",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Sodium Bicarbonate",
                                "dose": "975mg TID",
                                "route": "PO",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - ",
                                "duration": "",
                                "note": "Until Methotrexate (MTX) clearance (<0.1)"
                            },
                            {
                                "name": "Ondansetron",
                                "dose": "8mg Daily",
                                "route": "IV ",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - 5",
                                "duration": "over 15 minutes",
                                "note": ""
                            },
                            {
                                "name": "S.Lipase, S. Amylase, S. Fibrinogen",
                                "dose": "Daily",
                                "route": "",
                                "phase": "Other",
                                "day": "Day 1 - ",
                                "duration": "",
                                "note": "With routine labs, until MTX clearance"
                            },
                            {
                                "name": "Sodium Bicarbonate",
                                "dose": "450 mmol Daily",
                                "route": "IV",
                                "phase": "Pre-Chemo",
                                "day": "Day 1 - ",
                                "duration": "over 24 hours",
                                "note": "Until Methotrexate (MTX) clearance (<0.1)"
                            },
                            {
                                "name": "Vincristine",
                                "dose": "1.2mg/m² Once",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 1 , 8, 15, 22",
                                "duration": "over 15 minutes",
                                "note": "Maximum dose 2mg. Check bowel motion before giving dose"
                            },
                            {
                                "name": "Prednisolone",
                                "dose": "10mg/m² QID",
                                "route": "PO",
                                "phase": "Chemo",
                                "day": "Day 1 - 28",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Cytarabine ",
                                "dose": "40mg",
                                "route": "IT",
                                "phase": "Chemo",
                                "day": "Day 1",
                                "duration": "",
                                "note": "Intrathecal"
                            },
                            {
                                "name": "Doxorubicin",
                                "dose": "30mg/m² Once",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 2 - 3",
                                "duration": "over 10 minutes",
                                "note": ""
                            },
                            {
                                "name": "Methotrexate",
                                "dose": "4000mg/m²",
                                "route": "IV",
                                "phase": "Chemo",
                                "day": "Day 2",
                                "duration": "over 4 hours",
                                "note": "Start after urine pH >8, Check urine pH daily"
                            },
                            {
                                "name": "Calcium folinate",
                                "dose": "25mg Q6H",
                                "route": "IV push",
                                "phase": "Post-Chemo",
                                "day": "Day 3 - ",
                                "duration": "",
                                "note": "36 hours <b>AFTER START</b> of MTX. Continue until MTX clearance."
                            },
                            {
                                "name": "MTX",
                                "dose": "12mg",
                                "route": "IT",
                                "phase": "Chemo",
                                "day": "Day 4",
                                "duration": "",
                                "note": "Usually combine with Cytarabine IT"
                            },
                            {
                                "name": "L-Asparaginase",
                                "dose": "25,000 IU/m² Once",
                                "route": "IM",
                                "phase": "Chemo",
                                "day": "Day 8",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Methotrexate",
                                "dose": "12mg",
                                "route": "IT",
                                "phase": "Chemo",
                                "day": "Day 11",
                                "duration": "",
                                "note": "Intrathecal"
                            },
                            {
                                "name": "Bactrim ",
                                "dose": "960mg Q48H",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 28",
                                "duration": "",
                                "note": ""
                            },
                            {
                                "name": "Alfacalcidol",
                                "dose": "0.25mg Daily",
                                "route": "PO",
                                "phase": "Post-Chemo",
                                "day": "Day 1 - 30",
                                "duration": "",
                                "note": ""
                            }
                        ],
                        "NursesInfo": [
                            "<b>Asparaginase Monitoring:</b> Monitor fibrinogen and amylase/lipase levels. Inspect for DVT (swelling/redness) as Asparaginase significantly increases clot risk.",
                            "<b>Vincristine Safety:</b> Confirm bowel movements daily to assess for ileus",
                            "<b>Intrathecal Care:</b> Post-lumbar puncture, ensure the patient remains flat for 30–60 minutes to prevent spinal headache"
                        ],
                        "source": "Hospital Protocol"
                    }
                ]
            }
        }
    },
    "CML": {
        "Chronic Phase": {
            "goal": "To achieve <b>Major Molecular Response (MMR)</b> and maintain a normal life expectancy by managing the leukemia as a stable, long-term condition.",
            "protocols": [
                {
                    "protocolName": "Frontline Initiation (Imatinib)",
                    "drugs": [
                        {
                            "name": "Hydroxyurea",
                            "dose": "2,000mg",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 – 14",
                            "duration": "",
                            "note": "Only if WBC >100k; stop once TKI starts"
                        },
                        {
                            "name": "Imatinib",
                            "dose": "400mg",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 – 28",
                            "duration": "",
                            "note": "Take with a large glass of water and a meal"
                        }
                    ],
                    "NursesInfo": [
                        "Monitor for periorbital edema",
                        "Assess for muscle cramps; consider calcium/magnesium supplements",
                        "Verify patient is not taking St. John's Wort or systemic steroids",
                        "Monitor CBC every 2 weeks for Grade 3/4 neutropenia"
                    ],
                    "source": "NCCN Guidelines / ELN 2026"
                },
                {
                    "protocolName": "Frontline Initiation (Dasatinib)",
                    "drugs": [
                        {
                            "name": "Dasatinib",
                            "dose": "100mg",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 – 28",
                            "duration": "",
                            "note": "May take with or without food"
                        }
                    ],
                    "NursesInfo": [
                        "Screen for new-onset dry cough or shortness of breath (Pleural Effusion risk)",
                        "Strict Contraindication: Do not take with PPIs (Omeprazole, etc.); use antacids 2hrs apart",
                        "Baseline EKG required to monitor QTc interval",
                        "Instruct patient to report any unusual bruising or bleeding immediately"
                    ],
                    "source": "NCCN Guidelines / ELN 2026"
                },
                {
                    "protocolName": "Maintenance & Deep Molecular Response (DMR)",
                    "drugs": [
                        {
                            "name": "Nilotinib",
                            "dose": "300mg BID",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1–28",
                            "duration": "",
                            "note": "Twice daily; 12 hours apart"
                        }
                    ],
                    "NursesInfo": [
                        "Strict \"Fast State\": No food 2 hours before and 1 hour after dose",
                        "Monitor Lipase and Amylase levels every 3 months",
                        "Assess for peripheral arterial occlusive disease (leg pain when walking)",
                        "Schedule qPCR testing exactly every 3 months to track MMR/DMR status"
                    ],
                    "source": "ELN 2026"
                },
                {
                    "protocolName": "Refractory Induction (Omacetaxine)",
                    "drugs": [
                        {
                            "name": "Omacetaxine",
                            "dose": "1.25 mg/m²",
                            "route": "SC",
                            "phase": "Chemo",
                            "day": "Day 1 – 14",
                            "duration": "",
                            "note": ""
                        }
                    ],
                    "NursesInfo": [
                        "Rotate injection sites (thigh, abdomen, or upper arm)",
                        "Monitor for severe hyperglycemia (check blood glucose regularly)",
                        "Monitor for sever thrombocytopenia",
                        "Transition to 7-day maintenance once Hematologic Response is achieved"
                    ],
                    "source": "FDA/EMA Approved Label"
                },
                {
                    "protocolName": "TFR Stopping Protocol",
                    "drugs": [],
                    "NursesInfo": [
                        "Mandatory qPCR testing every 4 weeks for the first 6 months",
                        "Flag \"Loss of MMR\" if  BCR::ABL1 rises >0.1%",
                        "Educate patient on TKI Withdrawal Syndrome (acute joint/muscle pain)",
                        "Counsel patient that restarting TKI within 4 weeks of MMR loss is 95% successful"
                    ],
                    "source": "NCCN / ELN TFR Guidelines"
                }
            ]
        },
        "Blast Phase": {
            "goal": "The goal is to rapidly <b>restore the disease to a second Chronic Phase</b> and stabilize the patient to serve as a bridge to a life-saving Bone Marrow Transplant.",
            "protocols": [
                {
                    "protocolName": "Myeloid Induction (7+3 + TKI)",
                    "drugs": [
                        {
                            "name": "Cytarabine",
                            "dose": "100 - 200 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1 – 7",
                            "duration": "Continuous 24 hour infusion",
                            "note": ""
                        },
                        {
                            "name": "Daunorubicin",
                            "dose": "60 - 90 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1 - 3",
                            "duration": "",
                            "note": ""
                        },
                        {
                            "name": "Dasatinib",
                            "dose": "140 mg",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 – 28",
                            "duration": "",
                            "note": "Preferred TKI for Myeloid BP"
                        }
                    ],
                    "NursesInfo": [
                        "High risk of Tumor Lysis Syndrome (TLS); monitor Uric Acid, K+, and Phosphorus every 8–12 hours.",
                        "Perform daily skin assessments for \"Ara-C Rash\" or palmoplantar erythrodysesthesia.",
                        "<b>Dasatinib specific:</b> Monitor for pleural effusion (assess for dry cough and decreased breath sounds).",
                        "Maintain strict neutropenic precautions and monitor for febrile neutropenia."
                    ],
                    "source": "NCCN CML Guidelines 2026 / ELN Standard"
                },
                {
                    "protocolName": "Myeloid Salvage (FLAG-Ida + TKI)",
                    "drugs": [
                        {
                            "name": "Fludarabine",
                            "dose": "30 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 2 – 6",
                            "duration": "5 Days",
                            "note": "Over 30 mins; 4 hrs BEFORE Cytarabine"
                        },
                        {
                            "name": "Cytarabine",
                            "dose": "2000 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 2 – 6",
                            "duration": "5 Days",
                            "note": "Over 4 hrs; 4 hrs AFTER Fluderabine"
                        },
                        {
                            "name": "Idarubicin",
                            "dose": "8 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 4 - 6",
                            "duration": "3 Days",
                            "note": ""
                        },
                        {
                            "name": "Filgrastim (GCSF)",
                            "dose": "300 mg Daily",
                            "route": "SC",
                            "phase": "Post-Chemo",
                            "day": "Day 6 -",
                            "duration": "Until recovery",
                            "note": "Continue until ANC >1000 in 2 consecutive days"
                        }
                    ],
                    "NursesInfo": [
                        "Neuro-checks every 8 hours required for High-Dose Cytarabine (assess for cerebellar ataxia/nystagmus).",
                        "Corticosteroid eye drops (e.g., Prednisolone) required Q6H to prevent chemical conjunctivitis.",
                        "Idarubicin may cause red-colored urine (not hematuria); counsel the patient.",
                        "Fludarabine is highly immunosuppressive; monitor for opportunistic infections."
                    ],
                    "source": "MD Anderson / NCCN 2026"
                },
                {
                    "protocolName": "Lymphoid Induction (Hyper-CVAD + Ponatinib)",
                    "drugs": [
                        {
                            "name": "Cyclophosphamide",
                            "dose": "300 mg/m² Q12H",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1 - 3",
                            "duration": "6 doses",
                            "note": "Use with Mesna for bladder protection"
                        },
                        {
                            "name": "Dexamethasone",
                            "dose": "40 mg",
                            "route": "PO / IV",
                            "phase": "Chemo",
                            "day": "Day 1 – 4, 11 – 14",
                            "duration": "",
                            "note": "Monitor for steroid-induced hyperglycemia"
                        },
                        {
                            "name": "Vincristine",
                            "dose": "2 mg",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 4, 11",
                            "duration": "2 Doses",
                            "note": "Check for bowel movement before administration"
                        },
                        {
                            "name": "Doxorubicin",
                            "dose": "50 mg/m² Once",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 4",
                            "duration": "",
                            "note": ""
                        },
                        {
                            "name": "Ponatinib",
                            "dose": "30mg",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 – 28",
                            "duration": "",
                            "note": "Highly effective for Lymphoid BP"
                        }
                    ],
                    "NursesInfo": [
                        "<b>Ponatinib specific:</b> High risk for Arterial Occlusive Events (AOE); monitor for limb pain or coldness.",
                        "Monitor BP and cardiovascular status daily due to Ponatinib's risk profile.",
                        "<b>\"Vincristine is for IV use ONLY\":</b> Fatal if given by any other route (especially intrathecal).",
                        "Assess for Mesna compliance; encourage fluid intake to prevent hemorrhagic cystitis"
                    ],
                    "source": "NCCN 2026 / Ph+ ALL Standard"
                },
                {
                    "protocolName": "Intrathecal Prophylaxis",
                    "drugs": [
                        {
                            "name": "Methotrexate + Cytarabine",
                            "dose": "12 mg + 50 mg",
                            "route": "IT",
                            "phase": "Chemo",
                            "day": "Day 2",
                            "duration": "",
                            "note": "Administered via Lumbar Puncture"
                        }
                    ],
                    "NursesInfo": [
                        "Patient must remain flat (supine) for at least 1–2 hours post-procedure to prevent spinal headache.",
                        "Monitor for signs of increased intracranial pressure (severe headache, vomiting)."
                    ],
                    "source": "Standard Oncology Practice 2026"
                }
            ]
        }
    },
    "CLL": {
        "First-Line Therapy (Treatment-Naïve)": {
            "goal": "To achieve a long-term remission and reach uMRD (Undetectable Minimal Residual Disease) so treatment can be stopped.",
            "protocols": [
                {
                    "protocolName": "Continuous Targeted Therapy (BTK Inhibitors)",
                    "drugs": [
                        {
                            "name": "Zanubrutinib",
                            "dose": "160mg BID",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 - 28",
                            "duration": "",
                            "note": "Preferred for lower cardiac risk"
                        },
                        {
                            "name": "Acalabrutinib",
                            "dose": "100mg",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 - 28",
                            "duration": "",
                            "note": "Do not take with PPIs"
                        }
                    ],
                    "NursesInfo": [
                        "Monitor for new-onset atrial fibrillation (check pulse regularly)",
                        "Assess for minor bruising or bleeding (common with BTK inhibitors)",
                        "Monitor blood pressure; hypertension is a known long-term side effect"
                    ],
                    "source": "NCCN 2026 / ALPINE Study"
                },
                {
                    "protocolName": "IVO Induction (Sequential Start)",
                    "drugs": [
                        {
                            "name": "Obinutuzumab",
                            "dose": "100mg",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1",
                            "duration": "",
                            "note": "Split dose, Pre-medication for infusion reactions"
                        },
                        {
                            "name": "Ibrutinib",
                            "dose": "420mg Daily",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 - 28",
                            "duration": "Cycle 1 - 6",
                            "note": ""
                        },
                        {
                            "name": "Obinutuzumab",
                            "dose": "900mg",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 2",
                            "duration": "",
                            "note": "Pre-medication for infusion reactions"
                        },
                        {
                            "name": "Obinutuzumab",
                            "dose": "1000mg",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 8, 15",
                            "duration": "",
                            "note": "Pre-medication for infusion reactions"
                        },
                        {
                            "name": "Venetoclax",
                            "dose": "20mg ",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 22 - 28",
                            "duration": "",
                            "note": "5-week Ramp-Up: 20 mg x 7 days, then 50 mg, 100 mg, 200 mg, to 400 mg"
                        },
                        {
                            "name": "Ibrutinib",
                            "dose": "420mg Daily",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 29 - ",
                            "duration": "Cycle 2 - 6",
                            "note": ""
                        },
                        {
                            "name": "Obinutuzumab",
                            "dose": "1000mg Once",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 29",
                            "duration": "Cycle 2 - 6",
                            "note": "Day 1 of remaining cycle"
                        },
                        {
                            "name": "Venetoclax",
                            "dose": "50mg Daily",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 29 - 35",
                            "duration": "",
                            "note": "5-week Ramp-Up: 20 mg x 7 days, then 50 mg, 100 mg, 200 mg, to 400 mg"
                        },
                        {
                            "name": "Venetoclax",
                            "dose": "100mg Daily",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 36 - 42",
                            "duration": "",
                            "note": "5-week Ramp-Up: 20 mg x 7 days, then 50 mg, 100 mg, 200 mg, to 400 mg"
                        },
                        {
                            "name": "Venetoclax",
                            "dose": "200mg Daily",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 43 - 49",
                            "duration": "",
                            "note": "5-week Ramp-Up: 20 mg x 7 days, then 50 mg, 100 mg, 200 mg, to 400 mg"
                        },
                        {
                            "name": "Venetoclax",
                            "dose": "400mg Daily",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 50 - ",
                            "duration": "Cycle 2 - 6",
                            "note": "Continue dose until Cycle 6"
                        }
                    ],
                    "NursesInfo": [
                        "Each cycle is 28 days",
                        "Monitor for Tumor Lysis Syndrome (TLS) during the 5-week ramp-up",
                        "Ensure the patient is aggressively hydrated (2L/day) during ramp-up",
                        "Administer allopurinol as prescribed for uric acid management"
                    ],
                    "source": "Hospital protocol"
                }
            ]
        },
        "Second-Line / Relapsed Therapy": {
            "goal": "To bypass resistance (e.g., if they failed a BTKi, move to a BCL2i) and restore quality of life.",
            "protocols": [
                {
                    "protocolName": "Relapsed/Refractory (Ven-R)",
                    "drugs": [
                        {
                            "name": "Rituximab",
                            "dose": "375 - 500 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1",
                            "duration": "6 Cycles",
                            "note": "Usually given once monthly"
                        },
                        {
                            "name": "Venetoclax",
                            "dose": "400 mg",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 - 28",
                            "duration": "24 Months",
                            "note": "5-week ramp-up still required"
                        }
                    ],
                    "NursesInfo": [
                        "Monitor for neutropenia; G-CSF support may be needed",
                        "Check for \"Rituximab Infusion Reaction\" during the first hour of IV",
                        "Verify that the patient is not on strong CYP3A4 inhibitors (e.g., Grapefruit juice)"
                    ],
                    "source": "MURANO Study"
                }
            ]
        },
        "Salvage / Richter’s Transformation": {
            "goal": "",
            "protocols": [
                {
                    "protocolName": "R-CHOP",
                    "drugs": [
                        {
                            "name": "Rituximab",
                            "dose": "375 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day",
                            "duration": "",
                            "note": ""
                        },
                        {
                            "name": "Cyclophosphamide",
                            "dose": "750 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1",
                            "duration": "",
                            "note": "After Rituximab"
                        },
                        {
                            "name": "Doxorubicin",
                            "dose": "50 mg/m²",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1",
                            "duration": "",
                            "note": "After Cyclophosphamide"
                        },
                        {
                            "name": "Vincristine",
                            "dose": "1.4 mg/m² or max 2 mg",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1",
                            "duration": "",
                            "note": "After Doxorubicin; Make sure bowel movement today before administer."
                        },
                        {
                            "name": "Prednisolone",
                            "dose": "100mg Daily",
                            "route": "PO",
                            "phase": "Pre-Chemo",
                            "day": "Day 1 - 5",
                            "duration": "",
                            "note": "ONCE a day on days 1 to 5. Take in the morning with food. Dose for day 1 should be taken 60 minutes before Rituximab infusion."
                        },
                        {
                            "name": "Paracetamol",
                            "dose": "1000 mg",
                            "route": "PO",
                            "phase": "Pre-Chemo",
                            "day": "Day 1",
                            "duration": "",
                            "note": "60 mints before chemo"
                        },
                        {
                            "name": "Loratidine",
                            "dose": "10 mg",
                            "route": "PO",
                            "phase": "Pre-Chemo",
                            "day": "Day 1",
                            "duration": "",
                            "note": "60 mints before chemo"
                        }
                    ],
                    "NursesInfo": [
                        "Monitor for \"Red Devil\" (Doxorubicin) cardiac toxicity",
                        "Assess for Vincristine-induced neuropathy (numbness in fingers/toes)"
                    ],
                    "source": "<link>https://dub.sh/RCHOP</link>"
                }
            ]
        }
    },
    "APL": {
        "Induction Phase": {
            "goal": "To prevent fatal hemorrhage and force the immature \"promyelocyte\" blasts to mature into healthy white blood cells.",
            "protocols": [
                {
                    "protocolName": "APL Induction (ATRA + ATO)",
                    "drugs": [
                        {
                            "name": "Prednisolone",
                            "dose": "0.5 mg/kg Daily",
                            "route": "PO",
                            "phase": "Pre-Chemo",
                            "day": "Day 1 - 28",
                            "duration": "",
                            "note": "Round to nearest 5 mg, Taper off after 28 days."
                        },
                        {
                            "name": "Tretinoin (ATRA)",
                            "dose": "22.5 mg/m² BID",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 - 60",
                            "duration": "",
                            "note": "Round to nearest 10 mg"
                        },
                        {
                            "name": "Arsenic Tri Oxide (ATO)",
                            "dose": "0.15 mg/kg Daily",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "Day 1 -28",
                            "duration": "Over 2 hours",
                            "note": "Keep Mg >2 and K >4, Give premedication (Mg +/- K) IV before ATO"
                        }
                    ],
                    "NursesInfo": [
                        "<b>High Alert:</b> Monitor for Differentiation Syndrome (fever, weight gain, dyspnea); report to MD immediately.",
                        "Monitor daily Fibrinogen and PT/INR; keep Fibrinogen >1.5 with cryoprecipitate.",
                        "<b>Arsenic Monitoring:</b> Daily EKG is mandatory to check for QTc prolongation, inform physician if QTc >500 ms",
                        "Strictly avoid lumbar punctures or invasive procedures during the first 2 weeks due to bleeding risk."
                    ],
                    "source": "https://dub.sh/ATOATRA"
                }
            ]
        },
        "Consolidation": {
            "goal": "To eliminate any <b>\"Minimal Residual Disease\" (MRD)</b> and ensure the <b>PML::RARA</b> gene is no longer detectable.",
            "protocols": [
                {
                    "protocolName": "APL Consolidation",
                    "drugs": [
                        {
                            "name": "Tretinoin (ATRA)",
                            "dose": "22.5 mg/m² BID",
                            "route": "PO",
                            "phase": "Chemo",
                            "day": "Day 1 - 14",
                            "duration": "2 weeks on",
                            "note": "Given during the first 2 weeks of each ATO cycle"
                        },
                        {
                            "name": "Arsenic Tr Oxide (ATO)",
                            "dose": "0.15 mg/kg Daily",
                            "route": "IV",
                            "phase": "Chemo",
                            "day": "5 days/wk",
                            "duration": "4 weeks on",
                            "note": "cycles total (4 weeks on / 4 weeks off)"
                        }
                    ],
                    "NursesInfo": [
                        "Assess for peripheral neuropathy (numbness/tingling) caused by cumulative Arsenic exposure.",
                        "Monitor Liver Function Tests (ALT/AST) weekly; Arsenic can cause reversible hepatotoxicity.",
                        "Verify \"Molecular Remission\" via PCR testing at the end of the final cycle."
                    ],
                    "source": "https://dub.sh/ATOATRA"
                }
            ]
        }
    }
}
